Ligand validation:2YME

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 2YME designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2YME_NAG_E_1209	32%	19%	0.191	0.864	1.18	2.44	1	6	0	0	100%	0.9333
2YME_NAG_A_1206	15%	32%	0.206	0.769	0.89	1.88	-	6	0	1	100%	0.9333
2YME_NAG_I_1206	15%	37%	0.262	0.821	0.99	1.57	1	4	0	0	100%	0.9333
2YME_NAG_B_1206	12%	49%	0.27	0.795	0.66	1.29	-	3	0	1	100%	0.9333
2YME_NAG_F_1206	9%	34%	0.224	0.707	0.85	1.83	1	5	1	1	100%	0.9333
2YME_NAG_D_1208	8%	30%	0.299	0.766	0.68	2.22	-	5	0	1	100%	0.9333
2YME_NAG_J_1206	7%	40%	0.348	0.81	0.52	1.85	-	4	0	1	100%	0.9333
2YME_NAG_H_1206	7%	77%	0.299	0.751	0.3	0.61	-	-	0	0	100%	0.9333
2YME_NAG_C_1206	1%	55%	0.489	0.708	0.37	1.32	-	1	0	1	100%	0.9333
2WNL_NAG_H_400	64%	61%	0.14	0.938	0.42	1.04	-	-	0	0	100%	0.9333
2XZ5_NAG_D_1216	23%	9%	0.201	0.832	1.97	2.64	5	8	4	0	93%	0.9333
2UZ6_NAG_D_1206	22%	13%	0.167	0.791	1.68	2.43	2	7	0	1	93%	0.9333
5LXB_NAG_F_301	16%	14%	0.229	0.806	0.81	3.24	-	8	2	0	93%	0.9333
5OAJ_NAG_H_301	13%	76%	0.261	0.799	0.3	0.62	-	-	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.